Allegra Hurt By Stocking, Late Allergy Season, Not Other Products – Aventis
Aventis expects its allergy therapy Allegra to achieve single-digit growth in 2003 despite a slow first quarter, the company told analysts April 30
Aventis expects its allergy therapy Allegra to achieve single-digit growth in 2003 despite a slow first quarter, the company told analysts April 30